BAK Downgraded by HSBC -- Price Target Lowered to $1.50
HSBC downgraded Braskem (BAK) from Buy to Hold, lowering its price target from $6.50 to $1.50. GuruFocus values BAK at $5.14, suggesting a 70% undervaluation at its current price of $1.54. The company's GF Score is 53/100, indicating mixed financial performance.
How this was made
The 30-second read
Why it matters
HSBC’s downgrade and target cut could trigger short‑term selling, but value metrics may attract contrarian investors.
Market read
The downgrade provides fresh, material information for traders holding or watching BAK, with potential spill‑over to the chemical sector.
What to watch
Insider activity shows no recent sales, and the company’s cash‑flow issues may be temporary if commodity prices rebound.
Background
Braskem (BAK) is a Brazilian petrochemical producer with recent financial struggles, negative cash flow, and a low P/S ratio.
Ticker impact
HSBC downgraded Braskem from Buy to Hold and cut the price target to $1.50, a fresh analyst action that can move the stock.
likely pressure as the market prices in the lower target and reduced rating
Analyst downgrades with a 76% target reduction historically trigger short-term sell-offs, especially for a low‑priced, financially stressed stock.
Market effects
May weigh on other petrochemical and chemical stocks as analysts reassess valuation multiples.
Potentially drags Brazil‑focused equities and emerging‑market chemical exporters.
Limited to investors with exposure to Braskem or the broader chemical sector.
Counterpoint
The GF Value suggests the stock is still deeply undervalued, offering a contrarian buying opportunity despite the downgrade.
Key entities
- AnalystHSBC
Downgraded Braskem from Buy to Hold and cut price target to $1.50.
- CompanyBraskem SA
Brazilian petrochemical company, ticker BAK.
